Drugs and Devices

Infusion therapy: A model for safe practice in the home setting

Careful patient selection, provider and patient education, and well-planned and delivered patient care are critical to success. Takeaways: Home infusion therapy administration is associated with good outcomes but isn’t without risk as patients require an...

Make treatment accessible for opioid use disorder during the COVID-19 pandemic

During the current pandemic Americans are dealing with a complete or near complete disruption of everyday life. It is the same for persons with opioid use disorder (OUD), but they are far from the...

Opioid-induced respiratory depression

Be prepared and know the risks. Takeaways: Risk factors for opioid-induced respiratory depression include impaired rental clearance, high opioid tolerance, and sleep apnea history. Tools for assessing patient sedation levels include Richmond Agitation-Sedation Scale and...
cannabis

New research on possible adverse events to cannabis

A new study recently published in the Journal of Cannabis Research examines the potential “acute adverse reactions” associated with cannabis use. The study examined self-reported adverse reactions from 999 cannabis users and revealed that the...
anesthesia

An overview of neuraxial anesthesia

Please visit the ANA’s website to take the CE: https://www.nursingworld.org/continuing-education/an-overview-of-neuraxial-anesthesia/ Understand the basics so you can effectively manage your patients. Takeaways: Neuraxial anesthesia is the administration of medication into the subarachnoid or epidural space to produce...
cannabis

Cannabinoid hyperemesis syndrome explained

Learn how to identify this frequently misdiagnosed condition. Takeaways: Cannabinoid hyperemesis syndrome is a growing but poorly understood healthcare concern within the rising number of chronic, habitual cannabis users in the United States. Cannabinoid hyperemesis...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

The changing face of cystic fibrosis

It’s no longer a childhood illness. Takeaways: The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live 18 years and beyond. Longer life expectancy is due to...

Avoiding antipsychotic medication use in nursing home residents with dementia

Nurses are critical to improved resident well-being. Takeaways: Elderly patients using antipsychotic medications are at a 1.6 to 1.7 times increased of risk of death, and antipsychotic medications are associated with significant side effects. Individual...

Study shows reduced risk of cardiovascular disease during times of bereavement with daily aspirin...

A study published in the American Heart Journal explored the effects of aspirin and low dose metoprolol intake during early bereavement periods. Times of bereavement are often associated with an “increased risk of cardiovascular disease,”...

New vaccine eliminated breast cancer in first human patient

A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these cancers. The vaccine is currently being tested,...

New treatment for peanut allergy in children

The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia for children suffering from peanut allergy. Palforzia is intended to help “allergic reactions, including anaphylaxis, that may occur with accidental exposure...

Ultrasound-guided I.V. catheter insertion

Standardized protocols and education can improve patient safety, reduce costs, and enhance nursing practice. Takeaways: Achieving peripheral I.V. access can be difficult, even for experienced clinicians. Approximately 90% of hospitalized patients require some form of...